{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:58:28Z","timestamp":1791136708012,"version":"4.1.0"},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"21","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microarrays have been used to identify genes involved in cancer progression. We have now developed an algorithm that identifies dysregulated pathways from multiple expression array data sets without a priori definition of gene expression thresholds. Integrative microarray analysis of pathways (IMAP) was done using existing expression array data from localized and metastatic prostate cancer. Comparison of metastatic cancer and localized disease in multiple expression array profiling studies using the IMAP approach yielded a list of about 100 pathways that were significantly dysregulated (P &amp;lt; 0.05) in prostate cancer metastasis. The pathway that showed the most significant dysregulation, HIV-I NEF, was validated at both the transcript level and the protein level by quantitative PCR and immunohistochemical analysis, respectively. Validation by unsupervised analysis on an independent data set using the gene expression signature from the HIV-I NEF pathway verified the accuracy of our method. Our results indicate that this pathway is especially dysregulated in hormone-refractory prostate cancer. [Cancer Res 2007;67(21):10296\u2013303]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-2173","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T13:58:14Z","timestamp":1193925494000},"page":"10296-10303","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Integrative Microarray Analysis of Pathways Dysregulated in Metastatic Prostate Cancer"],"prefix":"10.1158","volume":"67","author":[{"given":"Sunita R.","family":"Setlur","sequence":"first","affiliation":[{"name":"1Department of Pathology, Brigham and Women's Hospital,"},{"name":"2Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Royce","sequence":"additional","affiliation":[{"name":"4Department of Molecular Biophysics and Biochemistry,"},{"name":"5Program in Computational Biology and Bioinformatics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sboner","sequence":"additional","affiliation":[{"name":"4Department of Molecular Biophysics and Biochemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Miguel","family":"Mosquera","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Brigham and Women's Hospital,"},{"name":"2Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Demichelis","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Brigham and Women's Hospital,"},{"name":"2Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias D.","family":"Hofer","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Brigham and Women's Hospital,"},{"name":"2Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten D.","family":"Mertz","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Brigham and Women's Hospital,"},{"name":"2Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gerstein","sequence":"additional","affiliation":[{"name":"4Department of Molecular Biophysics and Biochemistry,"},{"name":"5Program in Computational Biology and Bioinformatics, and"},{"name":"6Department of Computer Science, Yale University, New Haven, Connecticut; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Rubin","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Brigham and Women's Hospital,"},{"name":"2Harvard Medical School, and"},{"name":"3The Dana-Farber Cancer Institute, Boston, Massachusetts;"},{"name":"7The Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2022061623191682800_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin\u20082007; 57: 43\u201366.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2022061623191682800_B2","doi-asserted-by":"crossref","unstructured":"Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature\u20082001; 412: 822\u20136.","DOI":"10.1038\/35090585"},{"key":"2022061623191682800_B3","doi-asserted-by":"crossref","unstructured":"Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med\u20082002; 8: 816\u201324.","DOI":"10.1038\/nm733"},{"key":"2022061623191682800_B4","doi-asserted-by":"crossref","unstructured":"van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature\u20082002; 415: 530\u20136.","DOI":"10.1038\/415530a"},{"key":"2022061623191682800_B5","doi-asserted-by":"crossref","unstructured":"Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest\u20082004; 113: 913\u201323.","DOI":"10.1172\/JCI20032"},{"key":"2022061623191682800_B6","doi-asserted-by":"crossref","unstructured":"Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM. Mining for regulatory programs in the cancer transcriptome. Nat Genet\u20082005; 37: 579\u201383.","DOI":"10.1038\/ng1578"},{"key":"2022061623191682800_B7","doi-asserted-by":"crossref","unstructured":"Saxena V, Orgill D, Kohane I. Absolute enrichment: gene set enrichment analysis for homeostatic systems. Nucleic Acids Res\u20082006; 34: e151.","DOI":"10.1093\/nar\/gkl766"},{"key":"2022061623191682800_B8","doi-asserted-by":"crossref","unstructured":"Segal E, Friedman N, Koller D, Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet\u20082004; 36: 1090\u20138.","DOI":"10.1038\/ng1434"},{"key":"2022061623191682800_B9","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A\u20082005; 102: 15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"2022061623191682800_B10","doi-asserted-by":"crossref","unstructured":"Tomlins SA, Mehra R, Rhodes DR, et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet\u20082007; 39: 41\u201351.","DOI":"10.1038\/ng1935"},{"key":"2022061623191682800_B11","doi-asserted-by":"crossref","unstructured":"Zeeberg BR, Feng W, Wang G, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol\u20082003; 4: R28.","DOI":"10.1186\/gb-2003-4-4-r28"},{"key":"2022061623191682800_B12","doi-asserted-by":"crossref","unstructured":"Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics\u20082004; 20: 93\u20139.","DOI":"10.1093\/bioinformatics\/btg382"},{"key":"2022061623191682800_B13","doi-asserted-by":"crossref","unstructured":"Efron B, Tibshirani R. On testing the significance of sets of genes. Annal Appl Stat\u20082007; 1: 107\u201329.","DOI":"10.1214\/07-AOAS101"},{"key":"2022061623191682800_B14","doi-asserted-by":"crossref","unstructured":"Jiang Z, Gentleman R. Extensions to gene set enrichment. Bioinformatics\u20082007; 23: 306\u201313.","DOI":"10.1093\/bioinformatics\/btl599"},{"key":"2022061623191682800_B15","doi-asserted-by":"crossref","unstructured":"Kim SY, Volsky DJ. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics\u20082005; 6: 144.","DOI":"10.1186\/1471-2105-6-144"},{"key":"2022061623191682800_B16","doi-asserted-by":"crossref","unstructured":"Folks JL. Handbook of statistics v.4: Nonparametric methods. In: Krishnaiah PR and Sen PK, editors. Combination of independent tests. North-Holland, Amsterdam: Elsevier Science Pub. Co.; 1984. p.113\u201321.","DOI":"10.1016\/S0169-7161(84)04008-6"},{"key":"2022061623191682800_B17","doi-asserted-by":"crossref","unstructured":"Rubin MA, Varambally S, Beroukhim R, et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res\u20082004; 64: 3814\u201322.","DOI":"10.1158\/0008-5472.CAN-03-3881"},{"key":"2022061623191682800_B18","doi-asserted-by":"crossref","unstructured":"Rubin MA, Bismar TA, Andren O, et al. Decreased \u03b1-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev\u20082005; 14: 1424\u201332.","DOI":"10.1158\/1055-9965.EPI-04-0801"},{"key":"2022061623191682800_B19","doi-asserted-by":"crossref","unstructured":"Perner S, Hofer MD, Kim R, et al. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol\u20082007; 38: 696\u2013701.","DOI":"10.1016\/j.humpath.2006.11.012"},{"key":"2022061623191682800_B20","unstructured":"LaTulippe E, Satagopan J, Smith A, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res\u20082002; 62: 4499\u2013506."},{"key":"2022061623191682800_B21","doi-asserted-by":"crossref","unstructured":"Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A\u20082004; 101: 811\u20136.","DOI":"10.1073\/pnas.0304146101"},{"key":"2022061623191682800_B22","doi-asserted-by":"crossref","unstructured":"Suh J, Rabson AB. NF-\u03baB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem\u20082004; 91: 100\u201317.","DOI":"10.1002\/jcb.10729"},{"key":"2022061623191682800_B23","doi-asserted-by":"crossref","unstructured":"Bismar TA, Demichelis F, Riva A, et al. Defining aggressive prostate cancer using a 12-gene model. Neoplasia\u20082006; 8: 59\u201368.","DOI":"10.1593\/neo.05664"},{"key":"2022061623191682800_B24","doi-asserted-by":"crossref","unstructured":"Danielpour D. Functions and regulation of transforming growth factor-\u03b2 (TGF-\u03b2) in the prostate. Eur J Cancer\u20082005; 41: 846\u201357.","DOI":"10.1016\/j.ejca.2004.12.027"},{"key":"2022061623191682800_B25","doi-asserted-by":"crossref","unstructured":"Slack-Davis JK, Parsons JT. Emerging views of integrin signaling: implications for prostate cancer. J Cell Biochem\u20082004; 91: 41\u20136.","DOI":"10.1002\/jcb.10665"},{"key":"2022061623191682800_B26","doi-asserted-by":"crossref","unstructured":"Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE\u20082006; 2006: re13.","DOI":"10.1126\/stke.3572006re13"},{"key":"2022061623191682800_B27","doi-asserted-by":"crossref","unstructured":"Varambally S, Yu J, Laxman B, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell\u20082005; 8: 393\u2013406.","DOI":"10.1016\/j.ccr.2005.10.001"},{"key":"2022061623191682800_B28","doi-asserted-by":"crossref","unstructured":"Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res\u20082004; 64: 9209\u201316.","DOI":"10.1158\/0008-5472.CAN-04-2442"},{"key":"2022061623191682800_B29","doi-asserted-by":"crossref","unstructured":"Gasparian AV, Yao YJ, Kowalczyk D, et al. The role of IKK in constitutive activation of NF-\u03baB transcription factor in prostate carcinoma cells. J Cell Sci\u20082002; 115: 141\u201351.","DOI":"10.1242\/jcs.115.1.141"},{"key":"2022061623191682800_B30","doi-asserted-by":"crossref","unstructured":"Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD. Constitutive activation of I\u03baB kinase \u03b1 and NF-\u03baB in prostate cancer cells is inhibited by ibuprofen. Oncogene\u20081999; 18: 7389\u201394.","DOI":"10.1038\/sj.onc.1203160"},{"key":"2022061623191682800_B31","doi-asserted-by":"crossref","unstructured":"Shukla S, MacLennan GT, Fu P, et al. Nuclear factor-\u03baB\/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia\u20082004; 6: 390\u2013400.","DOI":"10.1593\/neo.04112"},{"key":"2022061623191682800_B32","doi-asserted-by":"crossref","unstructured":"Suh J, Payvandi F, Edelstein LC, et al. Mechanisms of constitutive NF-\u03baB activation in human prostate cancer cells. Prostate\u20082002; 52: 183\u2013200.","DOI":"10.1002\/pros.10082"},{"key":"2022061623191682800_B33","doi-asserted-by":"crossref","unstructured":"Ismail HA, Lessard L, Mes-Masson AM, Saad F. Expression of NF-\u03baB in prostate cancer lymph node metastases. Prostate\u20082004; 58: 308\u201313.","DOI":"10.1002\/pros.10335"},{"key":"2022061623191682800_B34","doi-asserted-by":"crossref","unstructured":"Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F. Nuclear localisation of nuclear factor-\u03baB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer\u20082005; 93: 1019\u201323.","DOI":"10.1038\/sj.bjc.6602796"},{"key":"2022061623191682800_B35","doi-asserted-by":"crossref","unstructured":"Tergaonkar V, Correa RG, Ikawa M, Verma IM. Distinct roles of I\u03baB proteins in regulating constitutive NF-\u03baB activity. Nat Cell Biol\u20082005; 7: 921\u20133.","DOI":"10.1038\/ncb1296"},{"key":"2022061623191682800_B36","doi-asserted-by":"crossref","unstructured":"Lessard L, Karakiewicz PI, Bellon-Gagnon P, et al. Nuclear localization of nuclear factor-\u03baB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res\u20082006; 12: 5741\u20135.","DOI":"10.1158\/1078-0432.CCR-06-0330"},{"key":"2022061623191682800_B37","doi-asserted-by":"crossref","unstructured":"Domingo-Domenech J, Mellado B, Ferrer B, et al. Activation of nuclear factor-\u03baB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer\u20082005; 93: 1285\u201394.","DOI":"10.1038\/sj.bjc.6602851"},{"key":"2022061623191682800_B38","doi-asserted-by":"crossref","unstructured":"Lambert PF, Ludford-Menting MJ, Deacon NJ, Kola I, Doherty RR. The NFKB1 promoter is controlled by proteins of the Ets family. Mol Biol Cell\u20081997; 8: 313\u201323.","DOI":"10.1091\/mbc.8.2.313"},{"key":"2022061623191682800_B39","doi-asserted-by":"crossref","unstructured":"Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science\u20082005; 310: 644\u20138.","DOI":"10.1126\/science.1117679"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/21\/10296\/2576451\/10296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/21\/10296\/2576451\/10296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:17:11Z","timestamp":1655417831000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/21\/10296\/533820\/Integrative-Microarray-Analysis-of-Pathways"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":39,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-2173","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370976.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370973.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370967.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370961.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370967","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370976","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370964","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370973","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370964.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370961","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370970","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370970.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496608.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496608","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}